Among cancer patients, psychological distress and accessibility of opioids often lead to chemical coping, a middle ground between addiction and proper adherence to a medication regimen. Chemical coping can diminish quality ...
Nov 8, 2023
0
0
One of the hallmarks of cancer cell development is its dependence on sugar, especially glucose, to grow and divide. Scientists have long been studying how to restrict or block this process that promotes tumor growth, called ...
Nov 7, 2023
0
1
Ready or not, patients with cancer are increasingly likely to find themselves interacting with artificial intelligence technologies to schedule appointments, monitor their health, learn about their disease and its treatment, ...
Nov 3, 2023
0
0
Your smartwatch could be the key to better, more personalized cancer care, UVA Cancer Center researchers suggest. A team of UVA Health researchers has demonstrated the potential of wearable and mobile devices such as smartwatches ...
Oct 31, 2023
0
1
A new thesis from Karolinska Institutet advocates end-of-life care that prioritizes the highest possible quality of life, avoids unnecessary or preventable risks and respects patient wishes.
Oct 31, 2023
0
0
Patients with ovarian cancer are 70% less likely to die three years after a multidisciplinary surgical approach is deployed, according to new research. The study from the Mater University Hospital on treating advanced ovarian ...
Oct 30, 2023
0
0
Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality health care is equal, regardless of socioeconomic status. ...
Oct 27, 2023
0
0
A breast self-exam is an inspection of your breasts that you do on your own. To help increase your breast awareness, you use your eyes and hands to regularly observe the look and feel of your breasts.
Oct 25, 2023
0
0
Patients with cancer whose oncologists receive payments from industry appear more likely to receive some non-recommended and low-value treatments, finds a US study published by The BMJ today.
Oct 25, 2023
0
0
For patients with chemorefractory metastatic colorectal cancer, the KRAS G12C inhibitor sotorasib in combination with the epidermal growth factor receptor inhibitor panitumumab results in longer progression-free survival ...
Oct 24, 2023
0
0
